TE
Teva
TEVA · NYSE
$36.77 +1.13% (+$0.41)
1M +0.61%
Market Cap $42.3B
P/E Ratio 59.92x
Div. Yield -
ROE 9.07%
Bulios Fair Price
$19.8
46.2% downside
Trenutna cena
$36.77
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TEVA trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
28 /100
Expensive EV/EBITDA 21.41x
P/S 2.44x
P/B 5.45x
Growth
40 /100
Stable FCF growth 3.28%
Book val. growth 0.45%
Rev. growth 4.96%
Profitability
57 /100
Moderate Net margin 4.08%
Op. margin 11.45%
FCF margin 7.79%
Quality
35 /100
Average ROE 9.07%
ROA 1.77%
Asset turnover 0.43x
Debt
15 /100
High Current ratio 0.88x
Int. coverage 1.78x
Net debt/EBITDA 5.10x
Stability
58 /100
Moderate Rev. volatility 1.04%
EPS volatility 192.14%
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TEVA
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Richard D. Francis
Employees
32,008
Headquarters
Tel Aviv
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report